| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 295.617 | 303.028 | 303.139 | 300.842 | 306.342 | 340.370 | 341.020 | 426.617 | 494.813 | 505.151 |
| Total Income - EUR | 310.033 | 317.261 | 313.780 | 312.551 | 321.309 | 349.151 | 348.940 | 434.815 | 501.180 | 507.178 |
| Total Expenses - EUR | 293.749 | 297.426 | 302.432 | 291.590 | 303.276 | 334.096 | 340.529 | 411.855 | 472.933 | 493.662 |
| Gross Profit/Loss - EUR | 16.284 | 19.835 | 11.348 | 20.961 | 18.033 | 15.054 | 8.411 | 22.960 | 28.247 | 13.516 |
| Net Profit/Loss - EUR | 13.555 | 15.809 | 8.212 | 17.835 | 14.820 | 12.040 | 5.415 | 18.994 | 23.426 | -1.130 |
| Employees | 6 | 6 | 6 | 6 | 5 | 6 | 6 | 6 | 7 | 6 |
Check the financial reports for the company - Fitofarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 54.341 | 52.319 | 45.260 | 58.845 | 49.107 | 41.804 | 34.327 | 26.308 | 25.274 | 22.430 |
| Current Assets | 70.251 | 84.929 | 68.454 | 66.508 | 98.943 | 126.438 | 126.990 | 167.047 | 198.700 | 164.099 |
| Inventories | 66.868 | 71.283 | 51.477 | 61.740 | 70.286 | 103.034 | 98.689 | 127.160 | 126.230 | 103.676 |
| Receivables | 2.860 | 13.359 | 1.048 | 7.685 | 2.762 | 4.492 | 4.831 | 5.359 | 6.863 | 6.978 |
| Cash | 523 | 287 | 15.930 | -2.917 | 25.896 | 18.900 | 23.470 | 34.527 | 65.607 | 53.445 |
| Shareholders Funds | 84.298 | 99.247 | 105.779 | 117.149 | 124.376 | 123.178 | 125.862 | 138.843 | 155.255 | 131.405 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 40.295 | 38.001 | 7.935 | 8.205 | 23.673 | 45.064 | 35.456 | 54.512 | 68.915 | 55.577 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Fitofarm Srl